NL-OMON56948尚未招募不适用
Pharmacokinetic - pharmacodynamic study of amifampridine modified release in LEMS patients - PKPD of amifampridine MR in LEMS patients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Age >18 years
- •2. Clinical diagnosis of LEMS
- •3. Presence of Voltage Gated Calcium Channel Antibodies (VGCC antibodies)
- •4. Current use of amifampridine modified release
- •5. Receiving a stable dose of amifampridine modified release
排除标准
- •1. The patient is unable to fill out the study questionnaires or be interviewed
- •in Dutch or English, or is unable to undergo the tests needed for the study, or
- •is unable to give informed consent for participation in the study.
- •2. The investigator can exclude patients for this trial which are deemed not
- •suitable for any reason.
研究者
相似试验
招募中
1 期
A Study to Evaluate the Pharmacokinetics of Afamelanotide in Patients with Erythropoietic Protoporphyria (EPP).Erythropoietic Protoporphyria (EPP)MedDRA version: 21.1Level: LLTClassification code: 10015289Term: Erythropoietic protoporphyria Class: 10010331CTIS2023-507311-35-00Clinuvel Europe Limited34
招募中
不适用
Bioequivalence Study of Somatropin in Healthy Human Volunteers..IRCT20130626013776N20AryaTinaGene Biopharmaceutical Co30
已完成
不适用
Bioequivalence Study of Pegfilgrastim in Healthy Human VolunteersIRCT20130626013776N8AryaTinaGene Biopharmaceutical Co24
已完成
不适用
Bioequivalence Study of Filgrastim in Healthy Human VolunteersHealthy volunteers.IRCT20130626013776N7AryaTinaGene Biopharmaceutical Co24
已完成
1 期
Pharmacokinetics of Afamelanotide in Erythropoietic Protoporphyria PatientsErythropoietic ProtoporphyriaNCT06388642Clinuvel Europe Limited28